EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Impact of renal function on antidiabetic drug selection in Japan: A real‐world analysis using the J‐ DREAMS database

Masashi Kubota iD, Mitsuru Ohsugi, Kohjiro Ueki iD

Journal of Diabetes Investigation · 2026-05 · 17 (5) · 801-809

DOI: 10.1111/jdi.70280 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes Investigation, online erschienen am 27.02.2026. Verfasst von Masashi Kubota und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine, Japan Institute for Health Security, Tokyo, Jap…. Hauptthemen laut MEDLINE: Hypoglycemic Agents, Diabetes Mellitus, Type 2, Kidney, Practice Patterns, Physicians'. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Dainippon Sumitomo Pharma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims To describe renal function‐specific prescribing patterns of antidiabetic drugs in Japanese patients with type 2 diabetes using real‐world data and to identify selection trends up to the second therapy. Materials and Methods We retrospectively analyzed data from the J‐DREAMS registry (2015–2023) to evaluate the proportions of first and second drug classes stratified by renal function (eGFR ≥60 vs

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypoglycemic AgentsDiabetes Mellitus, Type 2KidneyPractice Patterns, Physicians'HumansJapanRetrospective StudiesFemaleMaleAgedGlomerular Filtration RateMiddle AgedRegistriesDatabases, FactualSodium-Glucose Transporter 2 InhibitorsDipeptidyl-Peptidase IV InhibitorsGlucagon-Like Peptide-1 Receptor Agonists

Stichwörter der Autor:innen

Chronic renal insufficiencyDrug prescriptionsType 2 diabetes mellitus

Substanzen

Hypoglycemic AgentsSodium-Glucose Transporter 2 InhibitorsDipeptidyl-Peptidase IV InhibitorsGlucagon-Like Peptide-1 Receptor Agonists

Autor:innen und Institutionen

  • Department of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine, Japan Institute for Health Security, Tokyo, Japan.
  • Diabetes and Metabolism Information Center, National Center for Global Health and Medicine, Japan Institute for Health Security, Tokyo, Japan.
  • Diabetes Research Center, National Center for Global Health and Medicine, Japan Institute for Health Security, Tokyo, Japan.

ORCID-Profile: Masashi Kubota, Kohjiro Ueki

Förderung

  • Dainippon Sumitomo Pharma

Zitieren

APA

Kubota, M., Ohsugi, M., & Ueki, K. (2026). Impact of renal function on antidiabetic drug selection in Japan: A real‐world analysis using the J‐ DREAMS database. Journal of Diabetes Investigation, 17(5), 801-809. https://doi.org/10.1111/jdi.70280

Vancouver

Kubota M, Ohsugi M, Ueki K. Impact of renal function on antidiabetic drug selection in Japan: A real‐world analysis using the J‐ DREAMS database. Journal of Diabetes Investigation. 2026;17(5):801-809. doi:10.1111/jdi.70280

BibTeX
@article{Kubota2026,
  author = {Kubota, Masashi and Ohsugi, Mitsuru and Ueki, Kohjiro},
  title = {Impact of renal function on antidiabetic drug selection in Japan: A real‐world analysis using the J‐ DREAMS database},
  journal = {Journal of Diabetes Investigation},
  year = {2026},
  volume = {17},
  number = {5},
  pages = {801--809},
  doi = {10.1111/jdi.70280}
}
Kostenlos starten →